Expression of sulfotransferases and sulfatases in human breast cancer: impact on resveratrol metabolism.
暂无分享,去创建一个
M. Miksits | Katrin Wlcek | M. Svoboda | T. Thalhammer | I. Ellinger | G. Stefanzl | C. Falany | T. Szekeres | W. Jaeger
[1] L. Goodman,et al. The Pharmacological Basis of Therapeutics , 1941 .
[2] H. Bloom,et al. Histological Grading and Prognosis in Breast Cancer , 1957, British Journal of Cancer.
[3] W. Stigelman,et al. Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .
[4] N. Harada,et al. Elevated steroid sulfatase expression in breast cancers , 2000, The Journal of Steroid Biochemistry and Molecular Biology.
[5] H. Glatt,et al. N-Acetyltransferases, sulfotransferases and heterocyclic amine activation in the breast. , 2001, Pharmacogenetics.
[6] P. Oner,et al. Evaluation of leukocyte arylsulfatase-A activity in patients with breast cancer and benign breast disease. , 2001, Cancer letters.
[7] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[8] D. Ghosh,et al. Purification, characterization and crystallization of human placental estrone/dehydroepiandrosterone sulfatase, a membrane-bound enzyme of the endoplasmic reticulum , 2001, The Journal of Steroid Biochemistry and Molecular Biology.
[9] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[10] Kathleen Bove,et al. Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo. , 2002, Biochemical and biophysical research communications.
[11] Y. Miyoshi,et al. High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[12] S. Akinaga,et al. Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma. , 2003, Cancer research.
[13] G. Ecker,et al. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship. , 2004, Bioorganic & medicinal chemistry.
[14] V. Speirs,et al. Phyto-oestrogens and breast cancer chemoprevention , 2004, Breast Cancer Research.
[15] N. Seeram,et al. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. , 2004, Anticancer research.
[16] T. Szekeres,et al. Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship. , 2005, Biochemical pharmacology.
[17] M. Miksits,et al. Sulfation of resveratrol in human liver: Evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1 , 2005, Xenobiotica; the fate of foreign compounds in biological systems.
[18] C. la Vecchia,et al. Resveratrol and breast cancer risk , 2005, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[19] T. Thalhammer,et al. Altered expression of the hormone- and xenobiotic-metabolizing sulfotransferase enzymes 1A2 and 1C1 in malignant breast tissue. , 2005, International journal of oncology.
[20] C. Dabrosin,et al. Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. , 2006, Cancer letters.
[21] T. Szekeres,et al. Increased Transport of Resveratrol Across Monolayers of the Human Intestinal Caco-2 Cells is Mediated by Inhibition and Saturation of Metabolites , 2006, Pharmaceutical Research.
[22] D. Ghosh,et al. Human sulfatases: A structural perspective to catalysis , 2007, Cellular and Molecular Life Sciences.
[23] C. Falany,et al. Interactions of the human cytosolic sulfotransferases and steroid sulfatase in the metabolism of tibolone and raloxifene , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[24] S. Bhattacharyya,et al. Steroid sulfatase, arylsulfatases A and B, galactose-6-sulfatase, and iduronate sulfatase in mammary cells and effects of sulfated and non-sulfated estrogens on sulfatase activity , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[25] T. Thalhammer,et al. Metabolism and disposition of resveratrol in the isolated perfused rat liver: role of Mrp2 in the biliary excretion of glucuronides. , 2008, Journal of pharmaceutical sciences.
[26] M. Miksits,et al. Metabolism of resveratrol in breast cancer cell lines: impact of sulfotransferase 1A1 expression on cell growth inhibition. , 2008, Cancer letters.
[27] C. Falany,et al. 24-Hydroxycholesterol Sulfation by Human Cytosolic Sulfotransferases: Formation of Monosulfates and Disulfates, Molecular Modeling, Sulfatase Sensitivity, and Inhibition of Liver X Receptor Activation The online version of this article (available at http://dmd.aspetjournals.org) contains supplementa , 2009, Drug Metabolism and Disposition.
[28] M. Miksits,et al. Antitumor activity of resveratrol and its sulfated metabolites against human breast cancer cells. , 2009, Planta medica.
[29] J. Planas,et al. Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC. , 2010, Journal of pharmaceutical and biomedical analysis.